Term ends Oct 28, 2031 · High confidence
20-year base term ends Nov 4, 2031
Held by Novartis Pharma AG
Filed Feb 24, 2025 as application 19/061,831 · Granted Apr 7, 2026
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Nov 4, 2011
Nov 4, 2011
Term ends
Oct 28, 2031
Oct 28, 2031
Granted
Apr 7, 2026
Apr 7, 2026
base term
after the term ends
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,363,307, US 12,465,635, US 9,744,234.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
12
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 4, 2011, when application PCT/EP2011/069476, the earliest non-provisional in its chain, was filed (this one was filed Feb 24, 2025) | Nov 4, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,363,307, US 12,465,635, US 9,744,234) | capped to Oct 28, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 28, 2031 | High confidence |
Partial family
| Application PCT/EP2011/069476 | PCT application no patent term | no patent term |
| US 9,744,234 | In force May 2033 | May 2033 |
| US 10,363,307 | In force Oct 2031 | Oct 2031 |
| Application 16/439,423 | Abandoned not computed | not computed |
| US 11,534,491 | In force Mar 2032 | Mar 2032 |
| Application 17/127,758 | Abandoned not computed | not computed |
| Application 17/165,729 | Abandoned not computed | not computed |
| US 12,465,635 | In force Oct 2031 | Oct 2031 |
8 of 12 applications in this family shown, earliest filings first. Partial: 1 of the 12 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 1, 2025 Reel 70702, frame 521 | Mpofu, Shephard; Richards, Hanno; Thangavelu, Karthinathan | Novartis AG | Assignment of Assignor's Interest |
| Apr 1, 2025 Reel 70705, frame 137 | Machacek, Matthias | Novartis Pharma AG | Assignment of Assignor's Interest |
| Apr 1, 2025 Reel 70705, frame 142 | Novartis Pharma AG | Novartis AG | Assignment of Assignor's Interest |
| Jun 11, 2026 Reel 75712, frame 291 | Novartis AG | Novartis Pharma AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2031
Term ends Oct 28, 2031. Maintenance fees still fall due before then
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,363,307, US 12,465,635, US 9,744,234.
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.